Teva Pharmaceutical Industries Ltd. - New research by Teva has thrown a spotlight on how badly affected women are by #migraine. But behind those numbers are real people. Come and meet some
Teva notched a win in its migraine patent feud with Eli Lilly
With clock ticking on Teva migraine drug, analyst expresses doubt for approval | Fierce Pharma
AbbVie, Biohaven, Teva and Satsuma tackle migraine at AHS – PharmaLive
Teva tries to make something out of nothing with Ajovy approval | Evaluate
Eli Lilly (NYSE:LLY) Loses Migraine Drug Patent Trial to Teva
Eli Lilly ordered to pay $176.5 million to Teva in U.S. migraine drug patent trial
Ajovy Now Available in Autoinjector Device for Migraine Prevention - MPR
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Teva to suspend sales of Zecuity migraine patch
Teva stops selling migraine patch after reports of burns
Teva Shares Pop as FDA Approves Its Migraine Drug - TheStreet
First Approval for Fremanezumab-vfrm – Creative Biolabs rAb Blog
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug – PharmaLive
Teva v. Eli Lilly: Teva argues Lilly is infringing migraine drug patent in the United States - Harvard Journal of Law & Technology
Xconomy: Teva Wins FDA Nod for Migraine Drug, Sets Price in Line with Amgen's
Preventive Treatment of Migraine–AJOVY® (fremanezumab-vfrm) injection
Teva scraps Heptares migraine pact as lead drug nears clinic | Fierce Biotech
Teva shares rally as FDA approves troubled drugmaker's migraine treatment | The Times of Israel
No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds | Fierce Pharma
